Im
Immunai
New York NYFounded 2018150 employees
Private CapbiotechPrivateOncology
Platform: Immune Map AI
Market Cap
N/A
All Drugs
3
Clinical Trials
6
Failed / Terminated
3
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Rilucapivasertib | IMM-7670 | Phase 2/3 | 2 | GLP-1R | AML | ||
| IMM-5834 | IMM-5834 | Phase 2 | 2 | FGFR | ALSADPKD | ||
| IMM-2921 | IMM-2921 | Phase 1/2 | 2 | JAK2 | FTD |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)